IL6 and neoplasm: Leveraging sustained melanin production, BMB181 exhibits a robust capacity to induce tumor cell death through photonic hyperthermia as well as inhibit inflammatory cytokines such as tumor necrosis factor‐α (TNF‐α) and interleukin 6 (IL‐6) release.